Insys Therapeutics (INSY) Misses Q3 EPS by 2c

November 3, 2016 7:09 AM EDT
Get Alerts INSY Hot Sheet
Trade INSY Now!
Join SI Premium – FREE

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

Insys Therapeutics (NASDAQ: INSY) reported Q3 EPS of $0.00, $0.02 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $55.2 million versus the consensus estimate of $55.97 million.

For earnings history and earnings-related data on Insys Therapeutics (INSY) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment